Predicate |
Object |
contentType |
Journal Article |
endingPage |
9; author reply 1739 |
issn |
0028-4793 1533-4406 |
issueIdentifier |
18 |
pageRange |
1739; author reply 1739-9; author reply 1739 |
publicationName |
The New England journal of medicine |
startingPage |
1739; author reply 1739 |
bibliographicCitation |
Tartarone A, Lerose R, Aieta M. Everolimus in HR-positive advanced breast cancer. N Engl J Med. 2012 May 03;366(18):1739; author reply 1739–40. doi: 10.1056/nejmc1202719. PMID: 22551140. |
creator |
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c1e24fbf58f0d07f7408594391fe51f2 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_cacc9ee0e3223aa918e9474920cacae8 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_28666be3da3abbf733de92ce36a29b96 |
date |
2012-05-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
identifier |
https://pubmed.ncbi.nlm.nih.gov/22551140 https://pubmed.ncbi.nlm.nih.gov/22551139 https://doi.org/10.1056/nejmc1202719 |
isPartOf |
https://portal.issn.org/resource/ISSN/1533-4406 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/5985 https://portal.issn.org/resource/ISSN/0028-4793 |
language |
English |
source |
https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/ |
title |
Everolimus in HR-Positive Advanced Breast Cancer |
discusses |
http://id.nlm.nih.gov/mesh/M0029863 http://id.nlm.nih.gov/mesh/M0543256 http://id.nlm.nih.gov/mesh/M0456327 http://id.nlm.nih.gov/mesh/M0001108 |
hasPrimarySubjectTerm |
http://id.nlm.nih.gov/mesh/D058570Q000037 http://id.nlm.nih.gov/mesh/D001943Q000188 http://id.nlm.nih.gov/mesh/D000971Q000627 http://id.nlm.nih.gov/mesh/D000730Q000627 http://id.nlm.nih.gov/mesh/D047072Q000627 http://id.nlm.nih.gov/mesh/D020123Q000031 |
hasSubjectTerm |
http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D006801 |
discussesAsDerivedByTextMining |
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6442177 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7102 |